72 related articles for article (PubMed ID: 24939529)
1. [Recurrent mutations in RHOA and FYN in peripheral T cell lymphomas].
Couronné L; Bastard C; Bernard OA
Med Sci (Paris); 2014 May; 30(5):488-92. PubMed ID: 24939529
[No Abstract] [Full Text] [Related]
2. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
3. Multistep tumorigenesis in peripheral T cell lymphoma.
Sakata-Yanagimoto M
Int J Hematol; 2015 Nov; 102(5):523-7. PubMed ID: 25628103
[TBL] [Abstract][Full Text] [Related]
4. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
[TBL] [Abstract][Full Text] [Related]
5. The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature.
Manso R; Sánchez-Beato M; Monsalvo S; Gómez S; Cereceda L; Llamas P; Rojo F; Mollejo M; Menárguez J; Alves J; García-Cosio M; Piris MA; Rodríguez-Pinilla SM
Blood; 2014 May; 123(18):2893-4. PubMed ID: 24786457
[No Abstract] [Full Text] [Related]
6. RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
Miyoshi H; Sakata-Yanagimoto M; Shimono J; Yoshida N; Hattori K; Arakawa F; Yanagida E; Takeuchi M; Yamada K; Suzuki T; Moritsubo M; Furuta T; Chiba S; Ohshima K
Pathol Int; 2020 Sep; 70(9):653-660. PubMed ID: 32648273
[TBL] [Abstract][Full Text] [Related]
7. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
[TBL] [Abstract][Full Text] [Related]
8. Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.
Ottolini B; Nawaz N; Trethewey CS; Mamand S; Allchin RL; Dillon R; Fields PA; Ahearne MJ; Wagner SD
Blood Adv; 2020 Jun; 4(11):2392-2403. PubMed ID: 32484856
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus positive diffuse large B cell lymphoma with G17V RHOA mutation arising from peripheral T cell lymphoma, not otherwise specified.
Watanabe M; Mizuta S; Koba Y; Ukyo N; Tamekane A
Ann Hematol; 2018 Feb; 97(2):361-362. PubMed ID: 29063178
[No Abstract] [Full Text] [Related]
10. Variegated RHOA mutations in human cancers.
Kataoka K; Ogawa S
Exp Hematol; 2016 Dec; 44(12):1123-1129. PubMed ID: 27693615
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
Li T; Zhang B; Ye Y; Yin H
Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
[TBL] [Abstract][Full Text] [Related]
12. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
13. Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas.
de Pádua Covas Lage LA; Culler HF; Barreto GC; Reichert CO; Levy D; de Oliveira Costa R; Rocha V; Pereira J
Clin Epigenetics; 2022 Dec; 14(1):180. PubMed ID: 36536430
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA methyltransferase activity upregulates Fyn tyrosine kinase expression in Hut-78 T-lymphoma cells.
Kozłowska A; Jagodziński PP
Biomed Pharmacother; 2008 Dec; 62(10):672-6. PubMed ID: 18337055
[TBL] [Abstract][Full Text] [Related]
15. STK10 missense mutations associated with anti-apoptotic function.
Fukumura K; Yamashita Y; Kawazu M; Sai E; Fujiwara S; Nakamura N; Takeuchi K; Ando M; Miyazono K; Ueno T; Ozawa K; Mano H
Oncol Rep; 2013 Oct; 30(4):1542-8. PubMed ID: 23842845
[TBL] [Abstract][Full Text] [Related]
16. Rnh1 promotes differentiation and myelination via RhoA in oligodendrocytes.
Zhao CF; Liu Y; Que HP; Yang SG; Liu T; Liu ZQ; Hui HD; Liu S
Cell Tissue Res; 2013 Sep; 353(3):381-9. PubMed ID: 23624614
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.
Boddicker RL; Razidlo GL; Feldman AL
Small GTPases; 2019 Jan; 10(1):33-39. PubMed ID: 27898263
[TBL] [Abstract][Full Text] [Related]
18. RHOA mutations in peripheral T cell lymphoma.
Cools J
Nat Genet; 2014 Apr; 46(4):320-1. PubMed ID: 24675518
[TBL] [Abstract][Full Text] [Related]
19. Regulation of division in mammalian oocytes: implications for polar body formation.
Levi M; Kaplan-Kraicer R; Shalgi R
Mol Hum Reprod; 2011 May; 17(5):328-34. PubMed ID: 21498869
[TBL] [Abstract][Full Text] [Related]
20. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.
Kakiuchi M; Nishizawa T; Ueda H; Gotoh K; Tanaka A; Hayashi A; Yamamoto S; Tatsuno K; Katoh H; Watanabe Y; Ichimura T; Ushiku T; Funahashi S; Tateishi K; Wada I; Shimizu N; Nomura S; Koike K; Seto Y; Fukayama M; Aburatani H; Ishikawa S
Nat Genet; 2014 Jun; 46(6):583-7. PubMed ID: 24816255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
